Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is licensed in the UK for weight management in adults, and men use it just as much as women do. The clinical trials included large numbers of male participants, and the licensed eligibility criteria apply equally regardless of sex. Men with a BMI of 30 or above, or 27 or above with a weight-related health condition, may qualify for a private prescription following clinical assessment. You've probably landed here because you're wondering whether Mounjaro is genuinely suited to men, or whether the clinical conversation has been shaped around female biology. The short answer: it hasn't. Mounjaro works through gut-hormone receptors that function the same way across sexes, and the weight-loss results seen in the SURMOUNT-1 trial, published in the New England Journal of Medicine, were consistent across subgroups. These are prescription-only medicines, and a prescriber makes the final call on suitability — but there is no male-specific barrier to treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Men tend to find out about Mounjaro through routes that aren't always accurate: a gym conversation, a wellness influencer, a headline claiming it's a "wonder jab." The reality is more considered than that. Mounjaro (tirzepatide) is a once-weekly injection made by Eli Lilly, and its mechanism centres on activating two receptors (GIP and GLP-1) that are involved in appetite regulation and blood-sugar control. It slows the rate at which the stomach empties, which means food stays with you longer and hunger signals arrive later. That's the biology, and it applies whether you're male or female, though we've also written up how tirzepatide works specifically for women for anyone researching on behalf of a partner or comparing experiences.
What does differ between men and women is body composition. Men generally carry more skeletal muscle and proportionally more visceral (abdominal) fat. This matters in two ways. First, men may notice changes in abdominal measurements earlier than the scale reflects them, because visceral fat is metabolically active and tends to shift noticeably with GLP-1 class medicines. Second, because lean muscle is metabolically denser than fat, men who retain muscle through adequate protein intake and resistance exercise during treatment may preserve their resting metabolic rate more effectively. None of this changes the medicine's mechanism, but it is worth understanding as you think about what treatment alongside a changed diet and activity level will look like for you specifically. For a detailed look at how tirzepatide works in male physiology, we've written that up separately.
The SURMOUNT-1 trial reported average weight reductions of around 20–21% at the 15mg dose over 72 weeks. The study included thousands of adults with obesity, and results across subgroups (including male participants) were consistent with the overall findings. These are trial averages; individual results vary and depend on adherence, diet, activity and clinical supervision.
The UK licence covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition. Conditions that count include type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnoea, and cardiovascular disease, conditions that are statistically more common in men in the UK, and that carry their own risks over time.
Lower BMI thresholds apply for men from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds, in line with NICE guidance on ethnicity-adjusted risk. BMI is a starting point, not the whole story; a prescriber reviews the full clinical picture before approving any prescription.
For NHS access, NICE's technology appraisal TA1026 sets stricter thresholds for publicly funded treatment, with phased rollout based on BMI and number of qualifying conditions. Most men arriving at a private pharmacy like ours don't meet the current NHS criteria or don't want to wait. That's a legitimate reason to pursue a private prescription, provided you go through proper clinical assessment. You can explore what weight loss on Mounjaro looks like for men including realistic timelines and what influences them.
What men ask us at our pharmacy more often than anything else: "Will I actually qualify?" The honest answer is that we won't know until a prescriber has reviewed your answers, your weight, and your health background. The consultation is free, and that review happens the same day.
The most common side effects of Mounjaro are gastrointestinal, nausea, diarrhoea, constipation, indigestion and burping feature most often. They tend to be most noticeable in the first few weeks after starting or after a dose increase, then settle for most people as the body adjusts. Fatigue and headache are also reported, particularly early on.
There are rarer but more serious effects that require prompt medical attention. Severe, persistent abdominal pain that radiates to the back (with or without vomiting) needs same-day medical review, as it can indicate pancreatitis. The MHRA highlighted acute pancreatitis as a known, infrequent but potentially serious risk in a Drug Safety Update in January 2026. Men who drink alcohol regularly or have a history of gallbladder issues should flag this to their prescriber during assessment, as both are relevant risk factors. Signs of a serious allergic reaction, gallbladder symptoms, and significant dehydration following severe vomiting or diarrhoea also warrant medical advice without delay.
There are no male-specific contraindications that don't apply equally to women, but men sometimes underreport symptoms, which is one reason we've put together a dedicated guide on whether Mounjaro is suitable for men. A question our prescribers hear regularly is whether nausea is "normal." Usually it is, especially at the start, but if you're uncertain, aftercare exists for exactly that reason. You can also read about long-term use of Mounjaro and what sustained treatment involves.
Mounjaro is a prescription-only medicine. There is no legal route to obtain it in the UK without a prescription issued following genuine clinical assessment. That means no pharmacy, no website, and no service can legally hand it over without one, and if a seller is offering Mounjaro without that step, the product and the process are both suspect. The MHRA has warned about counterfeit weight-loss pens sold online, including fake tirzepatide products seized from illicit UK manufacturing sites as recently as late 2025.
The legitimate private route is straightforward. At a GPhC-registered pharmacy, you complete a free medical consultation. A GPhC-registered Independent Prescriber (a named clinician, not automated software) reviews your answers, verifies your identity and your weight, and makes a clinical decision. At nume, orders placed by 12pm on a weekday (think: before the school run) are dispatched the same day once approved and arrive the next working day via DPD, in plain packaging. You can verify our pharmacy on the GPhC register (registration 9012878).
If you want to understand the cost context before committing, our treatment overview page sets out what's included in a transparent single price, consultation, prescription, delivery and 7-day aftercare, with no subscription and no auto-renewal. If you'd like to see how Mounjaro compares with other approaches, our weight-loss page covers the options. When you're ready, start your free consultation and let a prescriber give you a straight answer about your suitability.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.